MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma

Andreana L. Rivera, Christopher E. Pelloski, Mark R. Gilbert, Howard Colman, Clarissa De La Cruz, Erik P. Sulman, B. Nebiyou Bekele, Kenneth D. Aldape

Research output: Contribution to journal › Article › peer-review

372 Scopus citations

Fingerprint

Dive into the research topics of 'MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology